Abstract
A novel metallo-β-lactamase gene, blaIMP-27, was identified in unrelated Proteus mirabilis isolates from two geographically distinct locations in the United States. Both isolates harbor blaIMP-27 as part of the first gene cassette in a class 2 integron. Antimicrobial susceptibility testing indicated susceptibility to aztreonam, piperacillin-tazobactam, and ceftazidime but resistance to ertapenem. However, hydrolysis assays indicated that ceftazidime was a substrate for IMP-27.
Cite
CITATION STYLE
Dixon, N., Fowler, R. C., Yoshizumi, A., Horiyama, T., Ishii, Y., Harrison, L., … Hanson, N. D. (2016). IMP-27, a unique metallo-β-lactamase identified in geographically distinct isolates of Proteus mirabilis. Antimicrobial Agents and Chemotherapy, 60(10), 6418–6421. https://doi.org/10.1128/AAC.02945-15
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.